OBJECTIVE: Despite excellent survival prognosis, children treated for craniopharyngioma experience significant morbidity. We examined the role of hypothalamic involvement (HI) in excessive daytime sleepiness (EDS) and attention regulation in children enrolled on a Phase II trial of limited surgery and proton therapy. METHODS: Participants completed a sleep evaluation (N = 62) and a continuous performance test (CPT) during functional magnetic resonance imaging (fMRI; n = 29) prior to proton therapy. RESULTS: EDS was identified in 76% of the patients and was significantly related to increased HI extent (p = .04). There was no relationship between CPT performance during fMRI and HI or EDS. Visual examination of group composite fMRI images revealed greater spatial extent of activation in frontal cortical regions in patients with EDS, consistent with a compensatory activation hypothesis. CONCLUSION: Routine screening for sleep problems during therapy is indicated for children with craniopharyngioma, to optimize the timing of interventions and reduce long-term morbidity.
OBJECTIVE: Despite excellent survival prognosis, children treated for craniopharyngioma experience significant morbidity. We examined the role of hypothalamic involvement (HI) in excessive daytime sleepiness (EDS) and attention regulation in children enrolled on a Phase II trial of limited surgery and proton therapy. METHODS:Participants completed a sleep evaluation (N = 62) and a continuous performance test (CPT) during functional magnetic resonance imaging (fMRI; n = 29) prior to proton therapy. RESULTS: EDS was identified in 76% of the patients and was significantly related to increased HI extent (p = .04). There was no relationship between CPT performance during fMRI and HI or EDS. Visual examination of group composite fMRI images revealed greater spatial extent of activation in frontal cortical regions in patients with EDS, consistent with a compensatory activation hypothesis. CONCLUSION: Routine screening for sleep problems during therapy is indicated for children with craniopharyngioma, to optimize the timing of interventions and reduce long-term morbidity.
Authors: Dean W Beebe; Stacey Simon; Suzanne Summer; Stephanie Hemmer; Daniel Strotman; Lawrence M Dolan Journal: Sleep Date: 2013-06-01 Impact factor: 5.849
Authors: J Lipton; J T Megerian; S V Kothare; Y-J Cho; T Shanahan; H Chart; R Ferber; L Adler-Golden; L E Cohen; C A Czeisler; S L Pomeroy Journal: Neurology Date: 2009-07-28 Impact factor: 9.910
Authors: A Pierre-Kahn; C Recassens; G Pinto; C Thalassinos; S Chokron; J C Soubervielle; R Brauner; M Zerah; C Sainte Rose Journal: Childs Nerv Syst Date: 2005-07-28 Impact factor: 1.475
Authors: Hermann L Müller; Georg Handwerker; Ursel Gebhardt; Andreas Faldum; Angela Emser; Reinhard Kolb; Niels Sörensen Journal: Cancer Causes Control Date: 2006-05 Impact factor: 2.506
Authors: Andrea Poretti; Michael A Grotzer; Karin Ribi; Eugen Schönle; Eugen Boltshauser Journal: Dev Med Child Neurol Date: 2004-04 Impact factor: 5.449
Authors: Marcos Di Pinto; Heather M Conklin; Chenghong Li; Thomas E Merchant Journal: Int J Radiat Oncol Biol Phys Date: 2012-08-04 Impact factor: 7.038
Authors: Ineke M Olsthoorn; Alice Ann Holland; Raymond C Hawkins; Allen E Cornelius; Muhammad Usman Baig; Grace Yang; Daniel C Holland; Wafik Zaky; Peter L Stavinoha Journal: Front Neurosci Date: 2022-06-23 Impact factor: 5.152
Authors: Shosha H M Peersmann; Martha A Grootenhuis; Annemieke van Straten; Gerard A Kerkhof; Wim J E Tissing; Floor Abbink; Andrica C H de Vries; Jacqueline Loonen; Leontien C M Kremer; Gertjan J L Kaspers; Raphaële R L van Litsenburg Journal: Cancers (Basel) Date: 2022-02-13 Impact factor: 6.639
Authors: Raja B Khan; Thomas E Merchant; Zsila S Sadighi; Mercedes S Bello; Zhaohua Lu; April Sykes; Merrill S Wise; Valerie M Crabtree; Jennifer Zabrowski; Andrea Simmons; Mary E Clark; Belinda N Mandrell Journal: J Neurooncol Date: 2017-11-08 Impact factor: 4.130
Authors: Kristin A Niel; Kimberly L Klages; Thomas E Merchant; Merrill S Wise; Donna Hancock; Mary Caples; Belinda N Mandrell; Heather M Conklin; Valerie Mclaughlin Crabtree Journal: Dev Med Child Neurol Date: 2021-03-22 Impact factor: 4.864